TBI icon

Trueblue

110 hedge funds and large institutions have $124M invested in Trueblue in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 35 increasing their positions, 49 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

2% more funds holding

Funds holding: 108 → 110 (+2)

1.02% less ownership

Funds ownership: 91.73% → 90.7% (-1%)

11% less capital inflows, than outflows

Capital inflows: $13.7M | Capital outflows: $15.4M

29% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 49

Holders
110
Holders Change
+2
Holders Change %
+1.85%
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
35
Reduced
49
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

TBI Hedge Fund Activity: Q4 2025 in Review

110 of the 8,287 institutional investors tracked by Wall St. Rank reported a position in Trueblue (TBI) for Q4 2025, worth a combined $124M — down 27% from $168M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new TBI positions and 8 closed out — a net gain of 3 holders — while 35 added to existing stakes and 49 trimmed.

The largest buyer was Boston Partners, adding an estimated $3.11M. The largest seller was Royce & Associates, cutting an estimated $3.48M.

  • 110 institutional investors held Trueblue (TBI) as of Q4 2025, up from 108 in Q3 2025.
  • Funds reported $124M of Trueblue stock for Q4 2025, down 27% quarter-over-quarter.
  • 11 funds opened new Trueblue positions in Q4 2025 and 8 closed out, a net change of +3 holders.
  • The largest Trueblue buyer in Q4 2025 was Boston Partners, an estimated $3.11M added.
  • The largest Trueblue seller in Q4 2025 was Royce & Associates, an estimated $3.48M sold.

Based on aggregated 13F filings for Q4 2025.